Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Guidant (GDT) -- Ignore unavailable to you. Want to Upgrade?

To: jbershad who wrote (83)	1/27/1998 8:33:00 PM
From: jbershad	Read Replies (1) \| Respond to of 235

Jan 27, 1998 (6:23 PM ET) - The Motley Fool Evening News Hambrecht & Quist and Cowen & Co. today both raised their estimates on the size of the U.S. stent market. Stents are medical devices used to help keep arteries open. The two brokerages raised their estimates of market size by 75%, from $800 million to $1.4 billion. Analysts say the technological merits of new stents are expanding the market and that revenues are growing as stents become longer. With that, H&Q raised its rating on Arterial Vascular Engineering (Nasdaq:AVEI - news) from "hold" to "strong buy," sending that stock up $8 5/8 to $64. Guidant Corp. (NYSE:GDT - news) gained $5 7/8 to $62 on the analyst move and on introducing a new implantable defibrillator in the U.S. Jerry